No scientific evidence, yet it first went viral on social media: "Bodybuilding circle miracle drug" peptide product deregulation document sent to White House for review, Hims & Hers (HIMS.US) surged 6% in one day.

Zhito Finance APP noted that Hims & Hers Health (HIMS.US) closed up 6% on Thursday, following reports that the U.S. Department of Health and Human Services (HHS) has submitted a temporary access policy regarding peptide products produced by compounding pharmacies to the White House for review.